2019

article thumbnail

What Are The Reasons Of Popularization And Future Aspects Of Pharma Franchise Business?

Fossil Remedies

POPULARIZATION AND FUTURE ASPECTS OF PHARMA FRANCHISE BUSINESS. Are you planning to launch a pharma franchise business? If yes, then it is essential to know everything about its prospects and reasons for its popularity. What are the primary reasons that affect it? Experts say that pharma franchise business is different, and hence, it is all the more important to understand it in detail. What is pharma franchise business? Pharma franchise is an agreement between the franchiser and franchisee.

75
article thumbnail

Faces of Fuld: Q&A with Kimberlee Luce, Senior Director, Consumer Products + Retail

Fuld

Kimberlee Luce has more than 20 years of experience in business research and consulting and has a unique blend of expertise rooted in opportunity analysis, competitor strategy and building effective distribution models in highly fragmented markets. She has provided market and competitive intelligence to some of the world’s largest and most ambitious companies taking her to places as diverse as Peru, Nigeria and China.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Science of Healthcare Congresses

Pharma Phorum

Research from Ashfield Meetings & Events clearly demonstrates that face-to-face meetings and events form a major part of continuing medical education (CME). National and international congresses have been identified as the primary event to attend by HCPs.

article thumbnail

How to Start a Pharmaceutical Distribution Company?

Fossil Remedies

STEPS TO START A PHARMACEUTICAL DISTRIBUTION COMPANY. When the pharma secto r is touching new heights year after year, it is a great idea to take the business benefits from it. Due to technological and scientific advances, pharmaceutical innovations are happening every second day. It means the opportunities are more than ever, especially if you are an enthusiastic entrepreneur. Start your pharmaceutical distribution company today. What does a pharma distribution company do?

67
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Faces of Fuld: Q+A with CEO, Diane Borska

Fuld

Diane Borska, CEO and President, maintains a deep history working with Fuld + Company and has held a variety of positions within the firm spanning an almost 20-year tenure. Over the course of her career, she’s crystalized her values and emphasizes mentoring, problem-solving and client-service which is demonstrated in her leadership style. We sat down with Diane to learn more about her background, her approach to client service, and her take on Fuld + Company’s key differentiators.

61
article thumbnail

Benefits of Third Party Manufacturing of Pharmaceuticals

Fossil Remedies

ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Many people know that the third-party business model gives you a chance to manufacture the products even if you do not have adequate finance. However, it is not the only thing that makes it a successful model. If you want to know about the other benefits, then continue reading the blog. Cost-effective production.

More Trending

article thumbnail

Why Strategic Business Leaders Should Question Fifth Generation Technology’s Readiness

Fuld

We Debunk 3 Popular Myths Amidst an International Race to 5G. As the pace of disruption increases , Fuld + Company acutely monitors disruptors with the power to upend a variety of industries, especially those that bring immense transformation on a global scale. While most believe groundbreaking innovations have the potential to cause global disruption, the truth is, there are a lot of factors for the public to consider before determining global disruption will take place.

article thumbnail

How to apply global brand strategies to every customer interaction

Pharma Phorum

Pharmaceutical companies spend a huge amount of time and resources on creating valuable brand strategies, but when they come to life there’s often a disconnect.

article thumbnail

Fuld + Company Welcomes Health & Life Sciences Practice Leader, Michael Ratcliffe

Fuld

Michael Ratcliffe brings both deep industry expertise and intelligence and strategy consulting capabilities to the firm. Boston, Mass.

article thumbnail

How Pharma Companies generate Franchise queries and Boost Business?

Fossil Remedies

What is the difference between the pharma sector and other sectors? Experts rate the pharma sector quite higher than others because of its huge potential for growth. Because of the tremendous progress in the Indian economy, every pharma company can expect good earnings.

article thumbnail

Innovative contracting in Europe – a Trojan horse?

Pharma Phorum

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing environment in Europe has become increasingly challenging over the years.

52
article thumbnail

How pharma marketing can stay ahead of the evolving customer journey

Pharma Phorum

Overview Join our live webinar taking place on Tuesday 23rd July at 16:00 BST / 11:00 EST / 08:00 PST. Customer journeys in pharma are changing, with important implications for the marketing supply chain.

article thumbnail

Orphan medicines launch excellence: sustaining launch success

Pharma Phorum

Launching orphan medicines excellently will become even more important over the next five years as more patients with rare diseases have pharmacotherapies available.

article thumbnail

Navigating new frontiers: Ways to find space in the future RA market

Pharma Phorum

Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab).

52
article thumbnail

Just What the Dr Ordered for UK Life Sciences? The 2nd Life Sciences Sector Deal

Pharma Phorum

Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the second Life Sciences Sector Deal and the long-term plan for the NHS.

52
article thumbnail

Cancer, genomics and personalised medicine: Modelling the future of oncology

Pharma Phorum

The prevalence of cancer is currently predicted to be higher than ever. Current statistics show 1 in 2 people in the UK and 1 in 2 men/1 in 3 women in the US will experience it at some stage in their lives. And yet the picture for patients is an improving one.

52
article thumbnail

Metrics to meaning: demonstrating the value of medical communications

Pharma Phorum

Medical affairs and publications teams are under increasing pressure to demonstrate effectively the success of the medical communications activities they undertake. Naturally, there are a huge number of metrics that could be used to measure and demonstrate medical communications value.

article thumbnail

Cost & Management of Oncology Combination Regimens

Pharma Phorum

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies). Payers are in a difficult spot regarding the cost and management of these regimens.

article thumbnail

Launch excellence in a disrupted world – challenges & opportunities

Pharma Phorum

Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care to specialty launch, but its future will be transformed even more radically. The advent of highly novel cell and gene therapies as well as prescription digital therapeutics is providing a serious set of forces for change in the market.

40
article thumbnail

Pharma Franchise Frequently Asked Questions & Answers

Fossil Remedies

PCD PHARMA FRANCHISE BUSINESS FAQS. A pharma franchise business model is when a company permits to sell the products by its name. It is an agreement between a franchiser which is typically a pharma manufacturing (or marketing) company where a franchisee is an individual entrepreneur or a small company that buys the license. If you are a budding entrepreneur who wants to start a business venture, then read the questions frequently asked about this business model.

article thumbnail

Which One Is Better – Pharma Marketing Company Or Pharma Manufacturing Company?

Fossil Remedies

Pharma Marketing Vs Pharma Manufacturing. Every year thousands of students pass the degree in pharmaceuticals with a lot of aspirations and dreams. Not everyone of them achieves the desired place; not because the sector doesn’t have enough opportunities or scope, but they fail to choose the right path. Whether to join a pharma marketing company and start marketing the products or open a manufacturing company; the decision is crucial.

article thumbnail

AI For Talent Acquisition in Tech – Part 3

Fuld

Fuld + Company engages with companies that are seeking confidence in their business strategy, including companies in the technology sector. These companies have increasing interest in dissecting how integrating AI tools can be a differentiator in a competitive environment—especially as AI’s role in the workplace remains ambiguous.